Skip to content

To detect a better adjuvant between magnesium sulphate and lignocaine for pretreatment with rocuronium

Comparison 0f pretreatment with magnesium sulphate versus lignocaine on intense neuromuscular blockade of rocuronium in elective surgeries: a randomized control trial - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/04/066229
Enrollment
54
Registered
2024-04-24
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Group A IV MAGNESIUM SULPHATE: The patient will receive Magnesium Sulphate IV (60mg/kg) diluted in 100ml Normal Saline over 10 minutes, 15 minutes before giving IV rocuronium (0.6mg/kg)

Sponsors

NIL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. American Society Of Anaesthesiologist (ASA) grading 1-2 2. BMI 18.5-29.9 3. All GA Surgeries lasting for more than 2 hrs

Exclusion criteria

Exclusion criteria: 1.Refused To Participate In The Study 2.Cardiac Conduction Abnormalities 3.Patients Having Neuromuscular Disease 4.known hepatic and renal dysfunction 5.Allergies to study drugs 6.Patients having electrolyte abnormalities 7.Patients on medications known to alter neuromuscular function 8.Patients having expected difficult mask ventilation or difficult laryngoscopy and intubation 9.Pregnant women

Design outcomes

Primary

MeasureTime frame
ONSET OF NEUROMUSCULAR BLOCKADE OF ROCURONIUMTimepoint: From the time of giving rocurnium to the time of achieving T1(first twitch) less than or equal to 5%

Secondary

MeasureTime frame
HEMODYNAMIC RESPONSE TO LARYNGOSCOPYTimepoint: Just before intubation, during laryngoscopy, just after intubation, 5 mins after intubation;time of first top-up dose of rocuroniumTimepoint: TOF Count 2-3;Time of neuromuscular recoveryTimepoint: TOF ratio more than or equal to 0.9;Total cumulative dose of RocuroniumTimepoint: At the end of last top-up dose

Countries

India

Contacts

Public ContactDr Priyanka Gupta

All India Institute Of Medical Sciences, Rishikesh

priyanka.anaes@aiimsrishikesh.edu.in9811894899

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026